Clinical Trials Logo

Clinical Trial Summary

This study evaluates whether the addition of intravenous magnesium sulphate or nimodipine to standard therapy (supportive care plus for all patients atropine and, for OP insecticide poisoned patients, pralidoxime) benefits patients after acute anticholinesterase self-poisoning with OP or carbamate insecticides.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03925025
Study type Interventional
Source University of Edinburgh
Contact Michael Eddleston, ScD
Phone 01312426776
Email m.eddleston@ed.ac.uk
Status Recruiting
Phase Phase 3
Start date December 11, 2020
Completion date June 2024

See also
  Status Clinical Trial Phase
Completed NCT02986763 - Evaluation of Pesticide Exposure in the General Population N/A
Completed NCT03647020 - Impact of Oocytes With CLCG on ICSI Outcomes and Their Potential Relation to Pesticide Exposure
Recruiting NCT05006638 - Assessing The Role Of Intravenous Lipid Emulsion As A Life Saving Therapy In Pesticides Toxicity Phase 4
Completed NCT01146496 - A Community Trial to Determine Whether 'Safe Storage' Reduces Pesticide Self-poisoning in Rural Asia N/A
Not yet recruiting NCT05310188 - Cholinesterase, Amylase, Lipase and Neutrophil-to-lymphocyte Ratio in Acute Pesticide Poisoning Cases